These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 2741713

  • 1. Serum testosterone response to low dose dexamethasone and combined contraceptive pill in subgroups of patients with polycystic ovary syndrome.
    Prelević G, Würzburger M, Perić L.
    Acta Med Iugosl; 1989; 43(2):113-20. PubMed ID: 2741713
    [Abstract] [Full Text] [Related]

  • 2. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
    Negri P, Agnello G, Borghesani F, Tomain L, Minisci N, D'Errico G, Cavallini AR.
    Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 4. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 5. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
    Singh KB, Mahajan DK, Wortsman J.
    J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
    [Abstract] [Full Text] [Related]

  • 6. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M.
    Acta Univ Palacki Olomuc Fac Med; 1989 Oct; 122():239-45. PubMed ID: 2530821
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 8. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 9. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
    Talbert LM, Sloan C.
    Obstet Gynecol; 1979 Jun; 53(6):694-7. PubMed ID: 572024
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE, Anania C, Malinak R.
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [Abstract] [Full Text] [Related]

  • 11. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ.
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneous results of serum testosterone obtained in multiple blood samples from women with idiopathic hirsutism in both basal and post-dexamethasone conditions.
    Scaglia HE, Aquilano D, Zylbersztein C, Spinedi E, Colombani M, Simon J, Encabo J.
    Reproduccion; 1981 Feb; 5(2):75-86. PubMed ID: 7262457
    [Abstract] [Full Text] [Related]

  • 13. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y, Mao WW, Chen YJ, Li MZ, Qiao J, Wang LN.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [Abstract] [Full Text] [Related]

  • 14. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M, Kovac T, Bujas M, Pusac R.
    Jugosl Ginekol Perinatol; 1985 Nov; 25(3-4):49-52. PubMed ID: 3938829
    [Abstract] [Full Text] [Related]

  • 15. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O, Papadias K, Konidaris S, Bakalianou K, Salakos N, Vrachnis N, Creatsas G.
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [Abstract] [Full Text] [Related]

  • 17. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
    Lisse K, Schürenkämper P, Friedrich W, Rutkowsky J.
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
    [Abstract] [Full Text] [Related]

  • 18. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
    Bardin CW, Hembree WC, Lipsett MB.
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
    [No Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
    Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):456-61. PubMed ID: 17105841
    [Abstract] [Full Text] [Related]

  • 20. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.
    Tan TT, Lui SK, Satgunasingam N, Khalid BA.
    Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.